Prostate cancer drug that can halve death risk to be offered to thousands in England
At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects Thousands of men with advanced prostate cancer in England are to be offered a drug that can halve the risk of death. In guidance published on Friday, the National (…)
Site référencé:
The Guardian (South&CentralAsia)
3333.jpg?width=140&quality=85&auto=format&fit=max&s=4ef98f38f4c778416f19eff8a360aecc, 3333.jpg?width=460&quality=85&auto=format&fit=max&s=1150db78d91fedf560db661d7de6d353, 3333.jpg?width=700&quality=85&auto=format&fit=max&s=b88b50e1202d2797417341d7e43a97ab
The Guardian (South&CentralAsia)
Right hair, right now : top stylists on the products they use themselves – and ones to avoid
17/10/2025
Jess Cartner-Morley on fashion : the number-one rule for coats this winter – make it long
15/10/2025
Sign up for the Filter UK newsletter : our free weekly buying advice
10/10/2024
Sign up for the First Edition newsletter : our free daily news email
20/09/2022
Sign up for the Feast newsletter : our free Guardian food email
9/07/2019